The Net Margin of Gan & Lee Pharmaceuticals (603087.SS) is 13.04%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
| Date | Value |
|---|---|
| 2023-12-31 | 13.04% |
| 2022-12-31 | -25.67% |
| 2021-12-31 | 40.22% |
| 2020-12-31 | 36.61% |
| 2019-12-31 | 40.32% |
| 2018-12-31 | 39.12% |
| 2017-12-31 | 45.56% |